Introduction {#sec1}
============

Urea is the primary end product of nitrogen metabolism in mammals, and humans typically produce more than 20 g of urea per day ([@B1]). One of the primary functions of the mammalian kidney is concentrating urea to \>100 times plasma levels for efficient excretion of this large osmotic load while minimizing water loss ([@B2]--[@B5]). Renal urea handling is a multistep process beginning with filtration of blood at the glomerulus followed by a countercurrent multiplication in the medulla. The countercurrent exchange is assisted by urea transporters (UTs) expressed in the descending thin limb of the loops of Henle (UT-A2 isoform), in erythrocytes (UT-B isoform), and in the inner 2/3 of the inner medullary collecting ducts (IMDC; UT-A1 and UT-A3 isoforms) ([@B4]--[@B7]). The IMCD transporters UT-A1 and UT-A3 increase the effective permeability of the tubular wall in the presence of vasopressin, thus allowing urea to freely pass into the inner medullary interstitial fluid where it can accumulate to \>1M concentration when water conservation is important.

Imaging renal solute handling could be a potentially valuable tool for the study of renal function. Several magnetic resonance imaging (MRI) studies have shown noninvasive sodium imaging using ([@B23]) Na-detected MRI ([@B8], [@B9]). Indirect urea detection via changes in the ^1^H water resonance after radio frequency saturation of the urea amide frequency has been shown ([@B10]). Recently, direct MRI of intravenously injected ^13^C-labeled urea ([@B11]--[@B15]) and numerous other small molecules ([@B16]--[@B26]) has been enabled using dynamic nuclear polarization ([@B27]). In this process, the isotopically enriched molecule is doped with an organic radical, cooled to liquid helium temperatures, and irradiated at microwave frequencies to achieve polarizations many orders of magnitude above thermal equilibrium values. After dissolution, the polarization decays exponentially with a time constant T1 which is typically 10-90 seconds for ^13^C-labeled carbonyl sites ([@B28], [@B18]). This method has been used to generate background-free angiograms in preclinical models using highly biocompatible contrast agents ([@B11], [@B29]).

The current study further investigates the physiological significance of hyperpolarized ^13^C renal urea relaxation times by linking these measurements to underlying steps of the urea handling process. In a prior study, ^13^C-detected hyperpolarized \[^13^C,^15^N~2~\]urea T2 mapping experiments performed in Sprague--Dawley rats gave uniform urea T2 values of ∼1 second throughout in the animal with the exception of the kidneys, where values between 4 and 15 seconds were noted ([@B30]). However, it remained unclear whether these long T2 signals originated from the renal vasculature, from within the tubular lumen, from the medullary interstitium, or some combination of these. In the first set of experiments presented here, a chase infusion of an intravascular macromolecular relaxation agent was performed after hyperpolarized \[^13^C,^15^N~2~\]urea injection but before T2 measurement. The gadolinium (Gd) chelates attached to the macromolecular complex substantially shortened the spin-lattice relaxation time of the hyperpolarized \[^13^C,^15^N~2~\]urea, thereby rapidly reducing its polarization and diminishing its signal. However, the macromolecular carrier restricts this effect to the vascular space. Therefore, the attenuation of the short and long T2 signals (compared with T2 measurements performed without the macromolecular relaxation agent in the control group) indicated whether the renal vasculature contributed to the long T2 signal. The second set of experiments investigated the hyperpolarized \[^13^C,^15^N~2~\]urea T2 response to rats on induced antidiuresis and osmotic diuresis. Prior experiments showed greater centralization of the hyperpolarized urea signal in the kidney in the rats on induced antidiuresis ([@B12]). In the antidiuresis state, the kidneys are in water conservation mode, and the inner medullary transporters UT-A1 and UT-A3 aid to maximally concentrate urea in the inner medulla (IM). During the osmotic diuresis state, low levels of circulating vasopressin and reduced UT-A1 and UT-A3 activity imply that urea excretion will be largely mediated by passive membrane diffusion ([@B31]). The experiments performed in this study more definitively attribute this effect to the UT-A1 and UT-A3 by comparing measurements of hyperpolarized \[^13^C,^15^N~2~\]urea T2 to those of a control molecule. Hyperpolarized bis-1,1-(hydroxymethyl)-1-^13^C-cyclopropane-^2^H~8~ (commonly abbreviated as HMCP or HP001) served as this control because it is nonendogenous and has no specific renal transport mechanisms aside from passive diffusion and tubular flow. The use of this control agent aids the accountability of the potential relaxation time changes due to transient glomerular filtration rate (GFR) changes or hydration status. To facilitate all relaxometry measurements, an alignment algorithm was created for the compensation of respiratory motion throughout image acquisition. A subspace denoising combined with a regularized estimation algorithm addressed the inherent difficulty and noise amplification inherent in multiexponential analysis. Finally, an additional T2-edited, high isotropic (\<2 mm^3^) resolution imaging sequence was shown as a potential method of discriminating the short T2 vascular and long T2 filtrate pools.

Methodology {#sec2}
===========

Animal Handling {#sec2-1}
---------------

Animal studies were performed under a protocol approved by the University of California San Francisco\'s Institutional Animal Care and Utilization Committee. Sprague--Dawley rats (mean mass, 400 g) were anesthetized with a 1.7% isofluorane/oxygen mixture under a constant flow rate of 1 L/min. Animals were imaged in the supine position inside the birdcage coil and thermally insulated via heat pad. Contrast agents were injected via lateral tail vein catheters. Rats were housed 3 per cage at the University of California San Francisco\'s Laboratory Animal Resource Center.

Hardware {#sec2-2}
--------

Imaging experiments were conducted in a GE 3 T clinical MRI (GE Medical Systems, Waukesha, Wisconsin) equipped with a rat-sized dual-tuned ^1^H/^13^C transceiver birdcage radio frequency coil (8 cm inner diameter) placed on the patient table. A HyperSense polarizer (Oxford Instruments, Oxford, UK) was used for dissolution dynamic nuclear polarization experiments.

Sample Preparation {#sec2-3}
------------------

Isotopically enriched \[^13^C,^15^N~2~\]urea and bis-1,1-(hydroxy-methyl)-1-^13^C-cyclopropane-^2^H~8~ were each doped with the trityl radical OX063 (Oxford Instruments) and Dotarem (Guerbet, Roissy, France) as previously described ([@B30], [@B21], [@B32]). Supplementary urea ^15^N labeling was necessary for the T2 increase afforded by the elimination of the scalar coupling of the second kind of relaxation pathway ([@B33], [@B30]). Bovine serum albumin (BSA) conjugated with an average of 23 Gd/diethylenetriaminepentaacetic acid (GdDTPA) chelates per BSA molecule (abbreviated as BSA-GdDTPA; molecular weight, ∼85 kDa) was synthesized using methods previously described ([@B34], [@B35]).

^13^C MRI Acquisition {#sec2-4}
---------------------

### T2 Mapping. {#sec2-4-1}

^13^C T2 mapping was performed using sequences previously described ([@B30]). Dynamic projection images were acquired in the coronal plane with 1 mm of in-plane resolution, 14 × 7 cm of field of view (FOV), 13 milliseconds of repetition time (TR), and 70 phase encodes per image, giving a temporal resolution of 910 milliseconds and total acquisition time of 18.2 seconds for all 20 echoes. Images were reconstructed with a simple 2-dimensional Fourier transform without spatial filtering. After reconstruction, some first-time-point images suffered from receiver over-ranging ([Supplemental Video 4](#SD4){ref-type="supplementary-material"}). These images were excluded, and an analysis was performed on the subsequent time points.

Relaxometric Data Analysis {#sec2-5}
--------------------------

### Motion Correction. {#sec2-5-1}

Periodic respiratory motion caused a 1-2 mm offset, which was largely resolved along the superior/inferior axis of the animal. To correct this observed shift, a simple search algorithm was developed, in which each image was aligned with its previous time point. Given that the motion was primarily 1-dimensional, a brute-force search was implemented, which translated each image in 1 mm increments over ±1 cm from the initial location along the superior/inferior axis (for a total of 20 sampling points). At each position, the normalized mutual information was calculated between the floating image and the previous time point, thus generating an mutual information versus translation curve as shown in [Figure 1](#F1){ref-type="fig"}. The shift that maximized this curve was then applied. An example of the motion-corrected images can be seen in [Supplemental Video 1](#SD1){ref-type="supplementary-material"}.

![Hyperpolarized ^13^C T2 mapping methodology. Hyperpolarized ^13^C-labeled substrates were injected via lateral tail vein catheter inside the magnetic resonance imaging (MRI) scanner. The T2 mapping sequence acquired coronal projection images at 0.9 seconds echo time (TE) intervals while playing 180° pulses for 18 seconds. Each image is then corrected for respiratory motion via rigid translation in the superior/inferior direction. The dynamic images are then denoised using a singular value decomposition (SVD)-based thresholding in the space/time dimensions. The signal component at each T2 is estimated using a regularized version of the T2 nonnegative least squares method, and the long and short T2 signal components are isolated by integrating the T2 distribution.](tom0021600350001){#F1}

### Subspace Denoising. {#sec2-5-2}

Outside of the kidneys, the majority of the ^13^C signal disappeared after the first few echoes ([Figure 1](#F1){ref-type="fig"}). This led to low-rank data matrices in the spatiotemporal dimensions. Therefore, a singular value decomposition-based denoising ([@B36]) could be used to better condition the ill-posed problem of multiexponential estimation ([@B37]--[@B40]). The 3-dimensional (3D) images (*x*, *y*, *t*) were concatenated along the *x* and *y* dimensions forming the matrix *I*(*r*, *t*). Singular values less than the largest 7 (out of 20) were set to 0. This singular value decomposition-thresholded matrix was then used for the regularized T2 estimation ([Figure 1](#F1){ref-type="fig"}).

### Multi-Exponential Analysis. {#sec2-5-3}

The T2 nonnegative least squares algorithm ([@B38]) was used for quantitative analysis of the time-decay data. This method uses a least squares inversion with nonnegativity constraints to estimate *s*(T2), the signal\'s T2 distribution at each pixel. The T2 nonnegative least squares is appealing, as it requires no *a priori* assumptions on the number of decay modes. However, regularization, necessary for the management of noise amplification, imposes assumptions of the shape of the distribution. *L*~2~ norm regularization smoothly produces varying distributions, whereas *L*~1~ norm regularization generates a sparse T2 spectra ([@B38]). We observed similar image appearance when using *L*~1~- and *L*~2~-regularized inversion of separation of short and long T2 signal components, but the sparse T2 spectra were easier to interpret visually ([Figure 3D](#F3){ref-type="fig"}). The inverse problem with *L*~1~ constraints was minimized as follows: Figure 3.\[^13^C,^15^N~2~\]urea T2 relaxometry after quenching the vascular signal. Timeline of the substrate injections and imaging (A). The left column shows images from the control experiment, and the center column shows the post-BSA-GdDTPA images. The \[^13^C,^15^N~2~\]urea T1/BSA-GdDTPA relaxivity curve is shown on the right. \[^13^C,^15^N~2~\]urea signal outside of the kidneys has T2 of \<2.5 seconds, which is strongly attenuated by BSA-GdDTPA (B). Pixel distributions from 4 animals are shown on the right. The long T2 urea signal component is confined to the kidneys and is unaffected by the BSA-GdDTPA chaser (C). Pixel distributions from 4 animals are shown on the right. T2 distributions of single pixels selected from the center of the kidneys are showing this short T2 signal attenuation (red arrow) (D). Single-pixel T2 decay curves (corresponding to the distributions in the left and center panels). $$\parallel As - y \parallel^{2} + \lambda \parallel s \parallel_{1},$$ where matrix *A* has the following elements: $$A_{i,j} = e^{- t_{j}/T_{2,i}}.$$

T2,~*i*~ is an array of 128 logarithmically spaced T2 values ranging from 3 to 20 seconds, *t*~*j*~ is the echo time (TE; 20 regularly spaced from 0.5 to 19 seconds), and *y*~*j*~ is the detected pixel signal-to-noise ratio (SNR) values of the *j*th echo. The regularization parameter λ was chosen to be 0.01% of λ~max~, where λ~max~ is the maximum possible value for which the solution is nonzero: λ ~max~ = 2max(*A*^T^ *Y*) ([@B41]).

From the distribution of *s*(T2), the signal *S*~α,β~ in the range *T*~2~ ∈ \[α, β\] was calculated by integrating the *s*(T2) from α to β. A mean (*T*~2~) measure in the range of *T*~2~ ∈ \[α, β\] was estimated by the first moment of the distribution: $$\left\langle T_{2} \right\rangle = \exp\left\{ \frac{\int_{\alpha}^{\beta}s(T_{2})\log T_{2}\, dT_{2}}{\int_{\alpha}^{\beta}s(T_{2})\, dT_{2}} \right\}.$$

The integration limits α and β were used to isolate short or long T2 species.

^13^C Urea/BSA-GdDTPA Relaxometry {#sec2-6}
---------------------------------

### ^13^C Imaging Experiments. {#sec2-6-1}

These experiments were designed to selectively quench the vascular ^13^C urea polarization while measuring the differential attenuation of the short and long T2 signal components. Analogous to previously reported experiments ([@B42]), a Gd carrier molecule was infused after the hyperpolarized ^13^C injection but before ^13^C detection. The paramagnetic Gd greatly reduces the T1 of the ^13^C molecule, thus causing rapid ^13^C polarization loss in regions where the ^13^C-labeled molecule and the Gd carrier are in proximity. This polarization loss manifests as a decreased signal during ^13^C imaging. This study used BSA as the carrier, which was conjugated with an average of 23 GdDTPA per BSA. This well-characterized blood pool agent has a high molecular weight (85 kDa) that prohibits extravasation and glomerular filtration on the subminute timescale ([@B34], [@B35]).

To estimate the efficacy of hyperpolarized ^13^C signal quenching, the ^13^C T1 relaxivity of \[^13^C,^15^N~2~\]urea with respect to BSA-GdDTPA was measured. BSA-GdDTPA was titrated in ∼0.2mM increments into a 1-mL vial containing 1M \[^13^C,^15^N~2~\]urea. At each titration point, the ^13^C urea T1 was measured via saturation recovery experiments at *B*~0~ = 3 T, T = 27°C. A linear fit was performed on the \[BSA-GdDTPA\] versus 1/T1 data points. Using this measured curve in conjunction with model-based estimates of the rats\' blood volumes ([@B43]), the in vivo T1 of ^13^C urea within the blood pool was roughly estimated.

In this study, 4 rats were imaged after 2 separate ^13^C urea injections: 1 with the BSA-GdDTPA chaser and 1 without to act as the control experiment. Because of the persistence of the BSA-GdDTPA in the blood pool, the chaser experiment was always performed after the control. [Figure 3A](#F3){ref-type="fig"} shows a schematic of the experimental timeline. Rats were injected with 3 mL, 150mM hyperpolarized \[^13^C,^15^N~2~\]urea solution over 12 seconds. The hyperpolarized urea was then allowed to diffuse for 28 seconds, and the ^13^C T2 mapping sequence was initiated 40 seconds after the beginning of injection; 2 hours later, a second \[^13^C,^15^N~2~\]urea infusion was performed over 12 seconds. The hyperpolarized urea was then allowed to diffuse for 20 seconds, then 1 mL, 0.59mM BSA-GdDTPA (15mM GdDTPA) was injected over 1 second. The chaser was allowed to diffuse for 7 seconds, and then the ^13^C T2 mapping sequence was initiated again 40 seconds after the beginning of the urea injection.

### Data Analysis. {#sec2-6-2}

Image noise was estimated by the standard deviation of a signal-free region of the ^13^C images (before image denoising), and all image pixels were normalized by this measurement. Pixels with first-time-point-SNR of \>10 were included in the analysis. Multiexponential estimation \[equation [(1)](#FD1){ref-type="disp-formula"}\] was performed pixel-wise after image alignment and denoising. After calculation of *s*(T2), the short and long T2 signal components were isolated from the T2 distributions calculated at each pixel using the integration limits (α = 0.3 seconds, β = 2.5 seconds) for the short T2 component and (α = 2.5 seconds, β = 20 seconds) for the long T2 component. After separation of the short and long T2 signal components, the following metrics were compared: SNR, mean T2 \[from equation [(3)](#FD3){ref-type="disp-formula"} with the same integration limits\], and total number of pixels with SNR \>10, giving a total of 6 metrics for each animal. Mean values of SNR and T2 were computed from within manually delineated kidney margins for each animal. Each metric was compared via nonparametric Wilcoxon rank-sum test between the \[^13^C,^15^N~2~\]urea + BSA-GdDTPA experiments and control \[^13^C,^15^N~2~\]urea experiments. *P* \< .05 was used as the significance criteria. In addition, all pixels from the short T2 and long T2 maps from all 4 animals were binned by SNR and plotted on top of each other as an aid for visualizing the BSA-GdDTPA chaser effects.

### ^1^H MRI. {#sec2-6-3}

For qualitative visualization of the Gd carrier distribution, ^1^H-detected, T1-weighted images were acquired 5 minutes post infusion of BSA-GdDTPA. This was followed by an additional injection of 1 mL, 0.5mM low molecular weight (940 Da) Gd-DTPA without attached albumin (Magnevist, Bayer Schering, Berlin). Both Gd agents were imaged with the same ^1^H spoiled gradient echo sequence (flip angle = 35, TE/TR = 1.4/7 milliseconds, 3 averages, 0.8 mm isotropic resolution).

Diuresis/Antidiuresis Relaxometry {#sec2-7}
---------------------------------

### ^13^C Imaging Experiments. {#sec2-7-1}

The T2 response of hyperpolarized \[^13^C,^15^N~2~\]urea and the control molecule hyperpolarized ^13^C HMCP to induced antidiuresis and osmotic diuresis in rats was measured. The methods for inducing diuresis and antidiuresis were identical to those described previously ([@B12]). For the antidiuresis protocol, the rats were deprived of food and water for an overnight period of 16 hours. To induce osmotic diuresis, the rats were first deprived of food and water for 16 hours and then allowed free access to aqueous glucose (10% by mass) solution for 9 hours. In each experiment, the urea (3 mL, 150mM hyperpolarized \[^13^C,^15^N~2~\]urea) was injected at least 2 hours before the HMCP injection (3 mL, 125mM hyperpolarized HMCP). The T2 mapping sequence was initiated 40 seconds after the beginning of injection with identical acquisition parameters aside from a 4.5 kHz resonance frequency offset between urea and HMCP.

### Data Analysis. {#sec2-7-2}

A single mean (*T*~2~) value was calculated at each pixel from the *s*(T2) distribution by calculating the first moment \[equation [(3)](#FD3){ref-type="disp-formula"}\] over the full distribution (α = 0.3 seconds, β = 20 seconds). Using the full distribution to compute a single (*T*~2~) value simplified the comparison of 2 molecules with differing multiexponential T2 decay curves. Further, 4 maps were computed for each of the 3 animals: (*T*~2~) maps for \[^13^C,^15^N~2~\]urea and HMCP in diuresis and antidiuresis states. Histograms including all pixels binned by (*T*~2~) were plotted for each agent to visualize the effect of diuresis and antidiuresis states.

For quantitative comparison, the cortex, outer stripe of the outer medulla (OSOM), inner stripe of the outer medulla (ISOM), and IM were delineated in ^1^H localizer images. The (*T*~2~) values from each of the 4 maps were then binned, and a mean value for each map was calculated for each animal. Paired statistical tests were performed in each kidney region for each ^13^C agent in diuresis and antidiuresis states using the Wilcoxon rank-sum test. *P* \< .05 was used as the significance criteria.

### ^1^H MRI. {#sec2-7-3}

Animals were imaged in the coronal and axial planes using a T2-weighted ^1^H fast spin echo sequence with TR = 1 second, TE = 100 milliseconds, 32 echoes, and 0.8-mm in-plane resolution.

T2-edited 3D imaging {#sec2-8}
--------------------

The long TE MRI acquisition will filter out the short T2 signal components, and this may be used as an under-sampling method to reduce the total number of phase encodes for achieving a high-resolution image. A 3D steady-state free precession (SSFP) acquisition was initiated at 20, 25, and 30 seconds after the beginning of urea injection. This sequence used a large flip angle (θ = 120°) and an extremely long TE (3.5 seconds), allowing for editing out the vascular signal with enhancement of the long T2 filtrate. The unaliased FOV was chosen to cover only the kidneys in the 2 phase-encoded dimensions. Rasterized, linear phase encode ordering was used, so the TE was half the total acquisition duration. An acquisition matrix with size (42, 42, 14) was acquired over a (5,5,1.7) cm FOV in (L-R,S-I,A-P) coordinates, yielding a 1.2-mm isotropic pixel length. Further, 588 phase encodes were acquired with TR = 12 milliseconds for a total scan time of 7 seconds. A signal simulation adapted from Svensson et al. ([@B21]) was used to estimate the blood pool suppression for different ^13^C relaxation times: $$SNR = \frac{1}{\sqrt{N}}{\sum\limits_{n = 1}^{N}\sin}\frac{\theta}{2}\left\lbrack {\left( {E_{1}\cos\frac{\theta}{2}} \right)^{2} + \left( {E_{2}\sin\frac{\theta}{2}} \right)^{2}} \right\rbrack^{n/2}.$$

Here, θ is the flip angle, *N* is the number of phase encode steps, $E_{1} = \exp( - TR/T_{1}),\, E_{2} = \exp( - TR/T_{2})$, and TR is the repetition time.

Results {#sec3}
=======

^13^C Urea/BSA-GdDTPA Relaxometry {#sec3-1}
---------------------------------

The T1 relaxivity of the BSA-GdDTPA complex on \[^13^C,^15^N~2~\]urea was estimated to be 77 ± 10mM^−1^s^−1^ with respect to the BSA carrier, or 3.1 ± 0.4mM^−1^s^−1^ per GdDTPA chelate (*R*^2^ = 0.97) from saturation recovery experiments. [Figure 3A](#F3){ref-type="fig"}, right, shows the measured T1 relaxivity curve, with error bars indicating T1 measurement uncertainty from the intrinsic SNR. The estimated rat blood volume was 27 ± 3 mL ([@B43]). Therefore, at the expected in vivo BSA-GdDTPA of ∼0.024mM, the urea T1 should be ∼0.5 seconds. Although this calculation is extremely rough, as it ignores circulation or potentially differing relaxivity in vivo and in vitro, the 7-second delay should have been adequate for any hyperpolarized \[^13^C,^15^N~2~\]urea to undergo several T1 time constants of decay, leading to large polarization losses when in contact with BSA-GdDTPA.

[Figure 2](#F2){ref-type="fig"} shows a first echo \[^13^C,^15^N~2~\]urea image with ([Figure 2A](#F2){ref-type="fig"}) and without ([Figure 2B](#F2){ref-type="fig"}) the chaser injection of the macromolecular BSA-GdDTPA relaxation agent. This image shows a large suppression of the vascular \[^13^C,^15^N~2~\]urea signal throughout, as well as darkening of the interlobular branches of the renal artery ([Figure 2B](#F2){ref-type="fig"}). The darkening of the renal arterial branches indicates that the 7-second delay was adequate not only for bolus arrival of the BSA-GdDTPA to the kidneys but also for the BSA-GdDTPA to cause substantial \[^13^C,^15^N~2~\]urea polarization loss. These same arterial branches show up bright in a T1-weighted ^1^H image ([Figure 2c](#F2){ref-type="fig"}). No renal perfusion was detected with the BSA-GdDTPA agent up to 5 minutes after initial infusion. In contrast, the post-GdDTPA image ([Figure 2D](#F2){ref-type="fig"}) shows renal perfusion and bladder accumulation because this agent is freely filtered at the glomerulus ([@B44]).

![Attenuation of the hyperpolarized \[^13^C,^15^N~2~\]urea signal is anatomically consistent with the macromolecular Gd carrier. Large field of view (FOV) images are shown on the top, and the bottom panels are zoomed to the kidney. First time-point ^13^C urea MRI image (A). ^13^C urea MRI acquired 8 seconds after bovine serum albumin-Gd/diethylenetriaminepentaacetic acid (BSA-GdDTPA) infusion shows strong suppression of the vascular signal and interlobular arteries (red arrow) (B). ^1^H MRI acquired 5 minutes after BSA-GdDTPA infusion (C). The interlobular arteries show positive contrast in this image (green arrow) demonstrating that BSA-GdDTPA is confined to the vascular space on the imaging time scale. ^1^H MRI acquired 5 minutes after GdDTPA infusion (D). In contrast to BSA-GdDTPA (mass ∼85 kDa), GdDTPA (mass ∼938 Da) is freely filtered at the glomerulus (yellow arrow).](tom0021600350002){#F2}

The dynamic \[^13^C,^15^N~2~\]urea images acquired under T2 decay conditions initially showed greatly reduced signal at early TE when accompanied by the BSA-GdDTPA chaser. At later TE, however, the images converge and look nearly identical. This effect is most easily visualized in [Supplemental Video 2](#SD2){ref-type="supplementary-material"} as follows: by the seventh time point (corresponding to a 6.8-second TE), only urea within the kidneys is visible in both images, and the signal\'s spatial variation is nearly identical in the images with and without the BSA-GdDTPA chaser. The similarity persisted in all experiments until the end of imaging acquisition. At this TE, both images show urea signal throughout the cortex and medulla, and a dark rim is present at the OSOM. The later echo images were acquired up to 25 seconds after the infusion of the BSA-GdDTPA chaser and provide strong evidence that the slowly decaying \[^13^C,^15^N~2~\]urea signal component emanated from regions inaccessible to the BSA-GdDTPA.

Multiexponential relaxometry quantified this dissimilarity at early echoes and similarity at late echoes. [Figure 3, B](#F3){ref-type="fig"} and [C](#F3){ref-type="fig"} show the short T2 and long T2 signal components, respectively, with the latter appearing identical in the \[^13^C,^15^N~2~\]urea images with and without BSA-GdDTPA. [Figure 3D](#F3){ref-type="fig"} shows a single decay curve from a pixel selected from the center of the kidney with semilog axes. The 2 decay modes show up as peaks in the T2 distributions in [Figure 3D](#F3){ref-type="fig"}, with the short T2 component significantly reduced by the BSA-GdDTPA chaser. The SNR and T2 measurements from all 4 animals is presented in [Table 1](#T1){ref-type="table"}. The BSA-GdDTPA chaser caused a significant reduction in the short T2 SNR and T2 values, with the latter indicating enhanced transverse relaxation of the macromolecular agent. Nonsignificant reductions were observed in the number of short T2 pixels with SNR \>10. The long T2 SNR was unaffected by the BSA-GdDTPA chaser, as was the mean long T2 value.

###### 

^13^C urea *T*~2~ Multiexponential Relaxometry after Quenching the Vascular Signal

                                                                           \[^13^C, ^15^N~2~\]urea SNR^[†](#TF1-1){ref-type="table-fn"}^   \[^13^C, ^15^N~2~\]urea 〈*T*~2~〉 \[s\]^[†](#TF1-1){ref-type="table-fn"}^   Number of Pixels with SNR \>10^[‡](#TF1-2){ref-type="table-fn"}^                                          
  ----------------------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------ ------------- ------------- ----------- ---
  \[^13^C, ^15^N~2~\]urea                                                                           19.6 ± 4.3                                                             41.2 ± 4.5                                                             0.94 ± 0.05                              6.07 ± 1.04   3500 ± 1000   570 ± 40    4
  \[^13^C, ^15^N~2~\]urea + BSA-GdDTPA[\*](#TF1-3){ref-type="table-fn"}                             12.4 ± 2.2                                                             43.8 ± 2.9                                                             0.76 ± 0.07                              6.84 ± 1.50   1700 ± 1100   600 ± 100   4
  *p*[\*\*](#TF1-4){ref-type="table-fn"}                                                               0.029                                                                 0.343                                                                   0.029                                    0.200         0.114        0.886    

^†^ Mean values within manually-delineated margins around the kidney.

^‡^ Mean values over the entire animal.

\* The ^13^C urea/BSA-GdDTPA *T*~1~ relaxivity was 77 ± 10 mM^--1^s^--1^, or 3.1 ± .4 mM^--1^s ^--1^ per GdDTPA (*R*^2^ = .97).

\*\* Calculated via Wilcoxon rank sum test with data from the above two rows.

Diuresis/Antidiuresis Relaxometry {#sec3-3}
---------------------------------

During osmotic diuresis, the urea remains largely in the outer medulla and cortex at the imaging start time used (40 seconds after the beginning of a 12-second injection). During antidiuresis, a larger fraction of the urea is collected in the IM and papilla consistent with UT-A1 and UT-A3 transporter activity. When the acquisition delay allowed for inner medullary urea accumulation, large T2 increases were observed because of a strong inward T2 gradient. [Supplemental Video 3](#SD3){ref-type="supplementary-material"} shows the dynamic ^13^C urea at multiple TE. During antidiuresis, not only is greater inner medullary accumulation of the ^13^C urea observed but the signal also persists to very late TE.

[Figure 4](#F4){ref-type="fig"} shows T2 exponential relaxometry performed with both imaging agents in rats on induced diuresis and antidiuresis. Rather than selecting the short or long T2 components, the mean (*T*~2~) \[calculated in equation [(3)](#FD3){ref-type="disp-formula"} with α = 0.3 seconds, β = 20 seconds\] was used to simplify analysis. A large (*T*~2~) increase was observed in the IM and renal papilla with \[^13^C,^15^N~2~\]urea during antidiuresis ([Figure 4A](#F4){ref-type="fig"}). This (*T*~2~) increase in the kidneys\' central region was not observed during diuresis ([Figure 4B](#F4){ref-type="fig"}). The signal distribution and (*T*~2~) of HMCP did not change significantly between antidiuresis and diuresis ([Figure 4, A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}, right). In the dynamic HMCP images shown in [Supplemental Video 4](#SD4){ref-type="supplementary-material"}, the late TE of the rats during diuresis and antidiuresis look similar. The summary of regional (*T*~2~) measurements from all 3 animals is presented in [Figure 4D](#F4){ref-type="fig"}. Statistically significant (*T*~2~) increases (*P* = .001) were observed with \[^13^C,^15^N~2~\]urea in the IM during antidiuresis.

![Hyperpolarized \[^13^C,^15^N~2~\]urea and HMCP relaxometry during antidiuresis and diuresis. Hyperpolarized \[^13^C,^15^N~2~\]urea and HMCP images are shown the left and right columns, respectively. HMCP showed increased medullary T2, but the effect did not vary between antidiuresis (A) and diuresis (B) states. Decay curves are selected from a single pixel in the inner medulla (IM) (C). The red arrow shows the persistence of signal to late TE. Mean renal pixel T2 distributions from 3 animals computed from average values over the cortex, outer stripe of the outer medulla (OSOM), inner stripe of the outer medulla (ISOM), and IM (D). The statistically significant change observed was the \[^13^C,^15^N~2~\]urea T2 in the IM consistent with the urea transporter (UT)-A1 and UT-A3 distribution.](tom0021600350004){#F4}

Both agents showed (*T*~2~) lengthening in the IM and papilla. Unlike \[^13^C,^15^N~2~\]urea, HMCP showed a small (*T*~2~) reduction in the cortex and outer medulla compared with blood. HMCP had a much higher (*T*~2~) in the vascular pool (3 seconds) compared with urea (1 seconds), which can be seen in the outer margins of the images in [Figure 4, A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}, right). With \[^13^C,^15^N~2~\]urea, (*T*~2~) values \>2 seconds were only observed within the kidney.

Signal in the ureters could be observed in osmotic diuresis conditions with both \[^13^C,^15^N~2~\]urea and HMCP. This can be visualized in the raw images [Supplemental Videos 3](#SD3){ref-type="supplementary-material"} and [4](#SD4){ref-type="supplementary-material"}, right panels. After image alignment, denoising, and summing late TE (TE = 7 to 20 seconds), the ureters are more easily visible ([Figure 5](#F5){ref-type="fig"}). The inner lumen of the rat ureter has a diameter between 50 and 150 μm ([@B45]), so a 1-mm-wide pixel (acquired in a perpendicular plane to the ureter axis) contains 10 nL of intra-ureter fluid. Although the signal was extremely faint, the persistence of the signal allowed for detectable ureter structure. HMCP had a much stronger signal than \[^13^C,^15^N~2~\]urea in the ureters likely because of its longer T1. Ureters were only visible in 2 of the 3 diuresis scans for HMCP and 1 of 3 scans for \[^13^C,^15^N~2~\]urea.

![^13^C ureter imaging during diuresis. 10 TE (from 5 to 14 seconds) were averaged after alignment and denoising to improve signal. Ureters could be observed in diuresis with both urea and HMCP (arrows). High urea reabsorption leads to substantial cortical and outer medullary urea signal compared with HMCP.](tom0021600350005){#F5}

T2-Edited 3D Imaging {#sec3-2}
--------------------

[Figure 6](#F6){ref-type="fig"} shows 3D \[^13^C,^15^N~2~\]urea images acquired at 1.2 mm isotropic resolution (1.73 mm^3^ pixel volume). These images are zoomed to a single kidney, but the full FOV in all 3 dimensions can be seen in the Supplemental [Video 5](#SD5){ref-type="supplementary-material"}. The efficacy of the blood pool suppression is evidenced by the low background signal and the dark interlobular arteries (magenta arrows on the image panels) and is concordant with the 3- to 5-fold suppression expected from simulation. The OSOM enhanced later than the cortex and ISOM (see the 20- and 25-second time points). Once inner medullary accumulation occurred, the IM and papilla were bright because of the sequence weighting (see simulations in [Figure 6A](#F6){ref-type="fig"}, right). Some residual aliasing is observed from the bright major arteries in the anterior/posterior dimensions, but these artifacts do not interfere substantially with visualization of renal anatomical structures.

![T2-edited 3-dimensional (3D) imaging. Sequence design (left) and signal simulations (right 3 panels) of a 1.7 mm^3^ isotropic resolution image (A). Simulations show the signal response expected from regions with T2 = 1.3 seconds (vascular pool), T2 = 4 seconds (cortex/outer medulla), and T2 = 10 seconds (IM/papilla). Blue arrows indicate sequence parameters used, and thus the signal response expected in the images. The long effective TE (4 seconds) of a 3D acquisition was used for blood pool signal suppression and for encoding the \[^13^C,^15^N~2~\]urea at 1.2-mm isotropic resolution (B). ^13^C urea images are acquired at 3 different delay times after 3 different injections. Blood pool suppression is evidenced by the dark interlobular arteries visible on both the \[^13^C,^15^N~2~\]urea and ^1^H fast spin echo images (magenta arrows).](tom0021600350006){#F6}

Discussion {#sec4}
==========

The minimal attenuation of the long T2 \[^13^C,^15^N~2~\]urea signals by the macromolecular chaser provided strong evidence that these long-T2 signals reside in the extravascular space. The confinement to the kidney further suggests that the long T2 signals represent urea from within the tubular lumen of the nephron, but contribution from the medullary interstitium may have been large. In the nephron segments with high urea permeability, such as the proximal tubule, the thin limbs of the loop of Henle, and the inner medullary collecting ducts ([@B46], [@B2]), urea easily passes through the tubular membrane and enters the interstitial fluid where it then may reenter the blood stream via the peritubular vascular network. The relative contribution of the tubular lumen and interstitium to the long T2 urea signals cannot be readily deduced from these data. Urea (mass ∼63 Da) and HMCP (mass ∼110 Da) are both freely filtered at the glomerulus, but the late TE urea image ([Figure 5](#F5){ref-type="fig"}, bottom left) still shows a substantial cortical signal. Residual cortical signal may signify the relative inefficiency of urea excretion without the aid of the UTs. The increase in the large inner medullary T2 observed during antidiuresis likely signifies a large interstitial fraction of the \[^13^C,^15^N~2~\]urea because vasopressin increases the urea permeability of the inner medullary collecting ducts by 400% ([@B5]). Furthermore, micro-computed tomography studies have shown that the blood supply in the IM is sparse and has a vascular volume fraction of \<0.2% in rats ([@B47]). These observations coincide with a theory that the \[^13^C,^15^N~2~\]urea T2 reports on an effective blood exposure time. Based on measurements in prior studies, \[^13^C,^15^N~2~\]urea experiences strong relaxation enhancement in plasma (T2 = 11 seconds) and whole blood (T2 = 5 seconds) compared with aqueous solution (T2 = 24 seconds) ([@B30]). Although the strongest in vitro relaxation enhancement was observed in whole blood, this value is more than double of that measured in vivo (T2 = 1.0 seconds), potentially indicating a large decrease in the apparent T2 because of the flow. Relaxation enhancement in erythrocytes could be because of a combination of high erythrocyte membrane permeability ([@B48]) and lengthened rotational correlation times due to high blood viscosity. Urea erythrocyte permeability is mediated by the erythrocyte isoform of the UT-B. A 20% reduction in the diffusion coefficient of urea has been reported in UT-B-expressed tissue xenografts compared with controls, likely indicating an increased intracellular pool size ([@B13]). Controlled experiments in erythrocytes reported changes in the resonant frequency ([@B49]) and reduction of the longitudinal T1 ([@B14]) of the intracellular \[^13^C\]urea. These results are concordant with shortening of the vascular T2 due to erythrocyte permeability. A recent study by Laustsen et al. noted a very large renal \[^13^C,^15^N~2~\]urea T2 change as a function tissue oxygenation ([@B50]), which further supports the hypothesis of a strong relaxation enhancement from the intra-erythrocyte urea pool, particularly from deoxyhemoglobin. An intriguing finding was that these changes were not observed in diabetic rodent models.

The lack of substantial cortical signals in the HMCP images in [Figure 5](#F5){ref-type="fig"} suggests that HMCP, similar to GdDTPA ([@B51], [@B52]), may not undergo any significant reabsorption as would be expected from a nonendogenous molecule. It is worth noting that other endogenous molecular probes for hyperpolarized ^13^C MRI such as pyruvate and lactate are also freely filtered but are nearly completely reabsorbed under normal conditions ([@B53], [@B54]). The lack of HMCP (*T*~2~) changes between diuresis and antidiuresis allows for the (*T*~2~) changes observed with \[^13^C,^15^N~2~\]urea to be more definitively attributed to the action of urea-specific transporters. This is important because hyperpolarized ^13^C experiments require relatively large contrast agent bolus volumes compared with the total animal blood volume. In each experiment, the rat was given 2 injections of 3 mL of hyperpolarized contrast agents spaced at least 2 hours apart. For the macromolecular relaxation experiments, the rat was given 2 additional injections of 1 mL of Gd contrast. The total injected volume equals ∼1/4 the animals\' total blood volume and had an unknown effect on cardiac output, GFR, and renal concentrating capacity. In addition, the urea mixture contained glycerol, which, in large doses, is known to cause a decrease in GFR in rats ([@B55]). Although it is difficult to conclude that this large aggregate injection volume had no transient effect on renal function, the apparent independence of HMCP (*T*~2~) measurements on diuresis/antidiuresis states offer imaging-based evidence that the renal concentrating capacity was relatively unchanged with repeat injections when the imaging was started at a constant duration after the injection.

The vascular T2 of HMCP measured here (T2 = 4 seconds at *B*~0~ = 3 T) is in agreement with a "worst case" value (T2 = 1.3 seconds at *B*~0~ = 2.35 T) reported previously using SSFP ([@B21]) but is over an order of magnitude higher than in in vivo measurements (T2 = 0.4 seconds at *B*~0~ = 9.4 T) reported using adiabatic refocusing pulses with surface coils ([@B56]). Recent studies report \[^13^C,^15^N~2~\]urea T2 values of 0.5 seconds at *B*~0~ = 9.4 T using a slice-selective, radial fast spin echo, suggesting the need for further study in the dependence of apparent T2 measurements on *B*~0~, contrast agent uptake in tissue, and acquisition type.

Interestingly, the \[^13^C,^15^N~2~\]urea T1 relaxivity of BSA-GdDTPA measured here (3.1 ± 0.4 mM^−1^s^−1^ per GdDTPA, *B*~0~ = 3 T) is more than an order of magnitude higher than that reported with gadodiamide and \[1-^13^C\]pyruvate (0.19 ± 0.01 mM^−1^s^−1^, *B*~0~ = 4.7 T) ([@B42]). This is likely attributable to the increased relaxivity from the slow correlation time of the macromolecule Gd carrier ([@B57]), but it may also signify some preferential binding of urea to albumin.

Some experimental limitations are noted. Multicomponent T2 relaxometry has well-known difficulties in accurately resolving closely spaced T2 values at the SNR, scan times, and echo spacing permissible on clinical MRI scanners ([@B39]). In this study, the SNR limitation was somewhat exacerbated by the polarization loss from T1 decay during the long delay periods between injection and imaging necessary for renal contrast agent accumulation. The observed T2 decay times were significantly longer than those typical of in in vivo ^1^H MRI, which permitted the coarse temporal sampling required by the single-shot, 1-mm-resolution planar readout. Furthermore, T2 differences between intra- and extravascular \[^13^C,^15^N~2~\]urea differed by a factor of at least 3. Decreasing the resolution would allow finer temporal sampling and increased SNR for the stabilization of T2 distribution estimation ([@B39]). T2 values less than the sampling time of 910 milliseconds are not expected to be resolved accurately. In nonselective in vivo Carr--Purcell--Meiboom--Gill experiments performed after infusion of hyperpolarized \[^13^C,^15^N~2~\]urea with finer temporal sampling (10 milliseconds), we observed approximately 30% of the total signal had a T2 of 300 milliseconds or less; the origin of this signal remains unknown. In addition, polarization variability will lead to random errors in comparing absolute SNR between experiments. Although prior measurements showed \<15% variability in \[^13^C,^15^N~2~\]urea polarizations when polarization and transport time are kept consistent ([@B30]), this potential random error will almost certainly be minimized with the use of automated transport injectors ([@B58]) and magnetically shielded transport pathways ([@B59]). Systematic errors may also arise in quantitative T2 mapping because of transmitter strength miscalibrations when using the transient phase of the SSFP signal. As derived by Scheffler, the exponential decay envelope of the signal is described by a positive eigenvalue ([@B60]), and is shown as follows: $$\lambda_{1} = \frac{1}{2}\left( {\left( {E_{1} - E_{2}} \right)\cos\theta + \sqrt{4E_{1}E_{2} + \left( {E_{1} - E_{2}} \right)^{2}\cos^{2}\theta}} \right),$$ with $E_{1} = e^{- TR/T1},\, E_{2} = e^{TR/T_{2}}$. The transmitter offset may be modeled as θ = 180° + δθ, and a Taylor expansion of λ~1~ gives the following equation: $$\lambda_{1} \approx a_{0} + a_{1}\delta\theta + a_{2}\delta\theta^{2} + .\,.\,.$$ with $$a_{0} = E_{2}$$ $$a_{1} = 0$$ $$a_{2} = \frac{E_{2}\left( {E_{1} - E_{2}} \right)}{E_{1} + E_{2}}$$

Nonideal π pulses will cause some apparent lengthening of the measured T2 by introducing some T1 weighting. However, these errors show up only as second- or higher-order terms of δθ. The second-order term is minimized when *E*~1~ ≈ *E*~2~, and this condition is expected to be better approximated in the longer T2 regions. Assuming T2 = 1.5 seconds and T1 = 20 seconds, flip angle errors δθ/θ up to 20% cause the apparent decay time to differ from T2 by \<10%.

Given the importance of urea in the urine concentrating mechanism, high-resolution imaging of renal urea handling could be a powerful tool for the investigation of renal physiology. This imaging technique could be applicable to the monitoring of diuretic drugs that act on UTs ([@B7], [@B6], [@B61]) or to study the effects of antineoplastic drugs, whose side effects include reduced urea concentrating ability ([@B62]). Radiologically, this method could address the inherent difficulty of renal perfusion evaluation on patients with impaired renal function and chronic kidney disease, as virtually all commonly used iodinated computed tomography contrast agents and Gd-based MRI contrast agents pose some hazards of acute renal failure in these patients ([@B63], [@B64]). Although urea clearance is well known to be an inaccurate marker for GFR estimation because of its significant reabsorption ([@B2]), ^13^C urea MRI could provide a qualitative assessment of renal perfusion such as is regularly performed on transplantation candidates, before and after ablation for renal cell carcinoma, and for the assessment of congenital urological abnormalities ([@B44], [@B65], [@B66]). All experiments in this study were performed on a clinical MRI scanner using infused urea doses that have been shown to be safe for humans with far advanced renal failure ([@B67]). Recent studies have also suggested the use of ^13^C urea as a biocompatible myocardial perfusion marker ([@B68], [@B69]).

Although T2-weighted imaging has been a standard clinical MRI evaluation for 3 decades ([@B70]), only a few studies have investigated T2 contrast for in vivo hyperpolarized ^13^C agents\' imaging ([@B71], [@B30], [@B72], [@B50]). In addition to chemical shift ([@B16], [@B73]--[@B77]) and diffusion-sensitive ([@B78], [@B13], [@B79], [@B72], [@B80]) imaging techniques, T2 relaxometry could be a very useful tool for probing the microenvironment of hyperpolarized ^13^C molecules in vivo, as it yields high signals, thus allowing for high-resolution encoding.

Imaging of 2 key steps of the renal urea handling process was enabled by a hyperpolarized ^13^C relaxometry. Selective quenching of the vascular hyperpolarized ^13^C signal with a macromolecular relaxation agent revealed that a long-T2 component of the \[^13^C,^15^N~2~\]urea signal originated from the renal extravascular space, thus allowing the vascular and filtrate pools of the \[^13^C,^15^N~2~\]urea to be distinguished via multiexponential analysis. The T2 response to induced diuresis and antidiuresis was performed with 2 imaging agents: hyperpolarized \[^13^C,^15^N~2~\]urea and hyperpolarized bis-1,1-(hydroxymethyl)-1-^13^C-cyclopropane-^2^H~8~ (control agent). During antidiuresis, large T2 increases in the IM and papilla were observed using the former agent only, suggesting that T2 relaxometry may be used to monitor the inner medullary UT-A1- and UT-A3-mediated urea concentrating process. A T2-edited, ultralong TE sequence was developed for sub-2 mm^3^ resolution 3D encoding of \[^13^C,^15^N~2~\]urea in the renal filtrate by exploiting relaxation differences in the vascular and filtrate pools.
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